Back
Outset Medical, Inc. Vs. Nebius Group NV Industry Stock Comparison
Sell
31
OM
Outset Medical, Inc.
Last Price:
$4.02
Seasonality Move:
9.73%
Buy
51
NBIS
Nebius Group NV
Last Price:
$108.86
Seasonality Move:
16.36%
Sell
31
Outset Medical, Inc. (OM)
is a Sell
Is Outset Medical, Inc. a Buy, Sell or Hold?
-
The current Outset Medical, Inc. [OM] share price is $4.01. The Score for OM is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
OM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Nebius Group NV (NBIS)
is a Buy
Is Nebius Group NV a Buy, Sell or Hold?
-
The current Nebius Group NV [NBIS] share price is $108.82. The Score for NBIS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
NBIS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
OM Stock Price Chart
What is Outset Medical, Inc.'s stock price today?
-
The Outset Medical, Inc. share price today is $4.01Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OM is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $108.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIS is experiencing buying pressure, which is a positive indicator for future bullish movement.
OM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1 | Buy |
| Relative Strength Index (14 RSI): | 62.32 | Buy |
| Chaikin Money Flow: | 80769 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.26 - 3.68) | Buy |
| Bollinger Bands (100): | (2.99 - 5.63) | Sell |
NBIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1 | Buy |
| Relative Strength Index (14 RSI): | 52.24 | Buy |
| Chaikin Money Flow: | 13258215 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (94.12 - 116.9) | Buy |
| Bollinger Bands (100): | (86.58 - 107.22) | Buy |
OM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.68 | Buy |
| 20-day SMA: | 3.47 | Buy |
| 50-day SMA: | 3.91 | Buy |
| 200-day SMA: | 9.89 | Sell |
| 8-day EMA: | 3.56 | Buy |
| 20-day EMA: | 2.56 | Buy |
| 50-day EMA: | 1.38 | Buy |
| 200-day EMA: | 0.41 | Buy |
NBIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.45 | Buy |
| 20-day SMA: | 108.76 | Buy |
| 50-day SMA: | 99.99 | Buy |
| 200-day SMA: | 89.14 | Buy |
| 8-day EMA: | 105.76 | Buy |
| 20-day EMA: | 106.36 | Buy |
| 50-day EMA: | 102.68 | Buy |
| 200-day EMA: | 86.85 | Buy |
Outset Medical, Inc. Earnings Growth & OM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.03 per share, an increase this year of $1.62 per share, and an increase next year of $0.49 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.82 per share, a decrease this year of $0.72 per share, and an increase next year of $1.68 per share.
Outset Medical, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nebius Group NV Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||